IndiaChina is facing a severe shortage of lab monkeys, which has caused their prices to double within a year. In June, a Chinese state laboratory paid $26,294 per cynomolgus macaque, nearly double the price from twelve months prior. This shortage is impacting the pharmaceutical industry, particularly as China aims to become a leading force in drug development. Biotech firms compare the difficulty of obtaining lab monkeys to securing Nvidia chips, highlighting the critical role these animals play in preclinical drug testing. The shortage is attributed to increased demand driven by China's growing role in clinical trials and drug innovation. Regulatory requirements, such as the need for three-year-old monkeys for toxicology tests, exacerbate the issue, as breeding cannot quickly resolve the shortfall. Some companies anticipate the shortage will persist until 2028, with potential solutions including imports from Cambodia.
Bias read (Center): The article presents a factual report on a market-driven issue affecting the pharmaceutical industry without overt ideological slant. It discusses economic and scientific challenges without taking a clear political position, balancing the impact on both domestic and international stakeholders.
